Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Medicinal Chemistry
  4. Fast Track Articles
  5. Fast Track Article
image of Mechanisms and Characteristics of Chronic Pain in Alzheimer’s Disease: A Narrative Review

Abstract

Alzheimer’s disease is a neurodegenerative illness that significantly diminishes patients’ quality of life. Chronic pain remains a major contributor to exacerbating patients’ well-being. This comprehensive review aims to explore the mechanisms underlying pain perception in AD as well as identify potential targets and future considerations for pain relief. AD causes structural and functional alterations in the affected brain, including shrinkage of gray matter volume and disruptions in brain network connectivity. Besides memory loss, pain is a significant yet often neglected symptom. Effective pain management in AD is challenged by the adverse effects of pain-relief medications and communication difficulties, especially as the disease progresses. Both non- and pharmacological interventions are currently used to alleviate pain in AD. Pharmacological options include opioids, nonsteroidal anti-inflammatory drugs, paracetamol/acetaminophen, and adjuvant pain relievers like antidepressants and antiepileptic medications, though these are not officially approved for pain relief in AD. Non-pharmacological strategies, such as exercise therapy, music therapy, Reiki, reflexology, and behavioral therapy, are preferred to prevent the side effects of medication. However, the use of these methods is limited due to a lack of high-quality research. The review highlights a crucial link between neurological changes in AD and the perception of pain, underscoring the need for customized pain management approaches for this population. Emphasizing non-pharmacological interventions could potentially improve pain management in AD patients, provided that further research supports their effectiveness.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673334477250204072429
2025-04-15
2025-05-29

  • From This Site

    /content/journals/cmc/10.2174/0109298673334477250204072429
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Lane C.A. Hardy J. Schott J.M. Alzheimer’s disease. Eur. J. Neurol. 2018 25 1 59 70 10.1111/ene.13439 28872215
    [Google Scholar]
  2. Scheltens P. De Strooper B. Kivipelto M. Holstege H. Chételat G. Teunissen C.E. Cummings J. van der Flier W.M. Alzheimer’s disease. Lancet 2021 397 10284 1577 1590 10.1016/S0140‑6736(20)32205‑4 33667416
    [Google Scholar]
  3. Bondi M.W. Edmonds E.C. Salmon D.P. Alzheimer’s disease: Past, present, and future. J. Int. Neuropsychol. Soc. 2017 23 9-10 818 831 10.1017/S135561771700100X 29198280
    [Google Scholar]
  4. Stelzmann R.A. Norman Schnitzlein H. Reed Murtagh F. Murtagh F.R. An english translation of Alzheimer’s 1907 paper, “über eine eigenartige erkankung der hirnrinde”. Clin. Anat. 1995 8 6 429 431 10.1002/ca.980080612 8713166
    [Google Scholar]
  5. Petersen R.C. Smith G.E. Waring S.C. Ivnik R.J. Tangalos E.G. Kokmen E. Mild cognitive impairment: Clinical characterization and outcome. Arch. Neurol. 1999 56 3 303 308 10.1001/archneur.56.3.303 10190820
    [Google Scholar]
  6. Pilipovich A.A. Vorob’eva O.V. Mild cognitive impairment: Modern aspects of diagnostics and therapy Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 2020 120 11 124 130 10.17116/jnevro2020120111124 33340307
    [Google Scholar]
  7. Braak H. Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991 82 4 239 259 10.1007/BF00308809 1759558
    [Google Scholar]
  8. Edmonds E.C. Eppig J. Bondi M.W. Leyden K.M. Goodwin B. Delano-Wood L. McDonald C.R. Heterogeneous cortical atrophy patterns in MCI not captured by conventional diagnostic criteria. Neurology 2016 87 20 2108 2116 10.1212/WNL.0000000000003326 27760874
    [Google Scholar]
  9. Gottesman I.I. Psychopathology through a life span-genetic prism. Am. Psychol. 2001 56 11 867 878 10.1037/0003‑066X.56.11.867 11785154
    [Google Scholar]
  10. Mauricio R. Benn C. Davis J. Dawson G. Dawson L.A. Evans A. Fox N. Gallacher J. Hutton M. Isaac J. Jones D.N.C. Jones L. Lalli G. Libri V. Lovestone S. Moody C. Noble W. Perry H. Pickett J. Reynolds D. Ritchie C. Rohrer J.D. Routledge C. Rowe J. Snyder H. Spires-Jones T. Swartz J. Truyen L. Whiting P. Tackling gaps in developing life-changing treatments for dementia. Alzheimers Dement. (N. Y.) 2019 5 1 241 253 10.1016/j.trci.2019.05.001 31297438
    [Google Scholar]
  11. Jury-Garfe N. You Y. Martínez P. Redding-Ochoa J. Karahan H. Johnson T.S. Zhang J. Kim J. Troncoso J.C. Lasagna-Reeves C.A. Enhanced microglial dynamics and paucity of tau seeding in the amyloid plaque microenvironment contributes to cognitive resilience in Alzheimer’s disease. bioRxiv 2023 27 550884 10.1101/2023.07.27.550884
    [Google Scholar]
  12. Schneider J.A. Arvanitakis Z. Leurgans S.E. Bennett D.A. The neuropathology of probable Alzheimer’s disease and mild cognitive impairment. Ann. Neurol. 2009 66 2 200 208 10.1002/ana.21706 19743450
    [Google Scholar]
  13. Breijyeh Z. Karaman R. Comprehensive review on Alzheimer’s disease: Causes and treatment. Molecules 2020 25 24 5789 10.3390/molecules25245789 33302541
    [Google Scholar]
  14. Chepisheva M.K. Spatial orientation, postural control and the vestibular system in healthy elderly and Alzheimer’s dementia. PeerJ 2023 11 e15040 10.7717/peerj.15040 37151287
    [Google Scholar]
  15. Crutch S.J. Lehmann M. Schott J.M. Rabinovici G.D. Rossor M.N. Fox N.C. Posterior cortical atrophy. Lancet Neurol. 2012 11 2 170 178 10.1016/S1474‑4422(11)70289‑7 22265212
    [Google Scholar]
  16. Graff-Radford J. Yong K.X.X. Apostolova L.G. Bouwman F.H. Carrillo M. Dickerson B.C. Rabinovici G.D. Schott J.M. Jones D.T. Murray M.E. New insights into atypical Alzheimer’s disease in the era of biomarkers. Lancet Neurol. 2021 20 3 222 234 10.1016/S1474‑4422(20)30440‑3 33609479
    [Google Scholar]
  17. Frisoni G.B. Fox N.C. Jack C.R. Jr Scheltens P. Thompson P.M. The clinical use of structural MRI in Alzheimer’s disease. Nat. Rev. Neurol. 2010 6 2 67 77 10.1038/nrneurol.2009.215 20139996
    [Google Scholar]
  18. Farrell M.J. Age-related changes in the structure and function of brain regions involved in pain processing. Pain Med. 2012 13 Suppl. 2 S37 S43 10.1111/j.1526‑4637.2011.01287.x 22497746
    [Google Scholar]
  19. Scahill R.I. Schott J.M. Stevens J.M. Rossor M.N. Fox N.C. Mapping the evolution of regional atrophy in Alzheimer’s disease: Unbiased analysis of fluid-registered serial MRI. Proc. Natl. Acad. Sci. USA 2002 99 7 4703 4707 10.1073/pnas.052587399 11930016
    [Google Scholar]
  20. Cardenas V.A. Chao L.L. Studholme C. Yaffe K. Miller B.L. Madison C. Buckley S.T. Mungas D. Schuff N. Weiner M.W. Brain atrophy associated with baseline and longitudinal measures of cognition. Neurobiol. Aging 2011 32 4 572 580 10.1016/j.neurobiolaging.2009.04.011 19446370
    [Google Scholar]
  21. van de Mortel L.A. Thomas R.M. van Wingen G.A. Grey matter loss at different stages of cognitive decline: A role for the thalamus in developing Alzheimer’s disease. J. Alzheimers Dis. 2021 83 2 705 720 10.3233/JAD‑210173 34366336
    [Google Scholar]
  22. Reiman E.M. Caselli R.J. Yun L.S. Chen K. Bandy D. Minoshima S. Thibodeau S.N. Osborne D. Preclinical evidence of Alzheimer’s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N. Engl. J. Med. 1996 334 12 752 758 10.1056/NEJM199603213341202 8592548
    [Google Scholar]
  23. Duara R. Grady C. Haxby J. Sundaram M. Cutler N.R. Heston L. Moore A. Schlageter N. Larson S. Rapoport S.I. Positron emission tomography in Alzheimer’s disease. Neurology 1986 36 7 879 887 10.1212/WNL.36.7.879 3487046
    [Google Scholar]
  24. Merskey H. Bogduk N. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the international association for the study of pain. 2nd Ed. Seattle Subcommittee on Taxonomy 1994 3 S1 226 3461421
    [Google Scholar]
  25. Raja S.N. Carr D.B. Cohen M. Finnerup N.B. Flor H. Gibson S. Keefe F.J. Mogil J.S. Ringkamp M. Sluka K.A. Song X.J. Stevens B. Sullivan M.D. Tutelman P.R. Ushida T. Vader K. The revised international association for the study of pain definition of pain: Concepts, challenges, and compromises. Pain 2020 161 9 1976 1982 10.1097/j.pain.0000000000001939 32694387
    [Google Scholar]
  26. Loeser J.D. Melzack R. Pain: An overview. Lancet 1999 353 9164 1607 1609 10.1016/S0140‑6736(99)01311‑2 10334273
    [Google Scholar]
  27. Moussa N. Ogle O.E. Acute pain management. Oral Maxillofac. Surg. Clin. North Am. 2022 34 1 35 47 10.1016/j.coms.2021.08.014 34750009
    [Google Scholar]
  28. Cohen S.P. Vase L. Hooten W.M. Chronic pain: An update on burden, best practices, and new advances. Lancet 2021 397 10289 2082 2097 10.1016/S0140‑6736(21)00393‑7 34062143
    [Google Scholar]
  29. Domenichiello A.F. Ramsden C.E. The silent epidemic of chronic pain in older adults. Prog. Neuropsychopharmacol. Biol. Psychiatry 2019 93 284 290 10.1016/j.pnpbp.2019.04.006 31004724
    [Google Scholar]
  30. Nikolenko V.N. Shelomentseva E.M. Tsvetkova M.M. Abdeeva E.I. Giller D.B. Babayeva J.V. Achkasov E.E. Gavryushova L.V. Sinelnikov M.Y. Nociceptors: Their role in body’s defenses, tissue specific variations and anatomical update. J. Pain Res. 2022 15 867 877 10.2147/JPR.S348324 35392632
    [Google Scholar]
  31. Yarnitsky D. Ochoa J.L. Differential effect of compression-ischaemia block on warm sensation and heat-induced pain. Brain 1991 114 2 907 913 10.1093/brain/114.2.907 2043957
    [Google Scholar]
  32. Monroe T.B. Gore J.C. Chen L.M. Mion L.C. Cowan R.L. Pain in people with Alzheimer’s disease: Potential applications for psychophysical and neurophysiological research. J. Geriatr. Psychiatry Neurol. 2012 25 4 240 255 10.1177/0891988712466457 23277361
    [Google Scholar]
  33. Larsson C. Hansson E.E. Sundquist K. Jakobsson U. Chronic pain in older adults: Prevalence, incidence, and risk factors. Scand. J. Rheumatol. 2017 46 4 317 325 10.1080/03009742.2016.1218543 27885914
    [Google Scholar]
  34. Breivik H. Collett B. Ventafridda V. Cohen R. Gallacher D. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur. J. Pain 2006 10 4 287 333 10.1016/j.ejpain.2005.06.009 16095934
    [Google Scholar]
  35. van Dijk A. McGrath P.A. Pickett W. VanDenKerkhof E.G. Pain prevalence in nine- to 13-year-old schoolchildren. Pain Res. Manag. 2006 11 4 234 240 10.1155/2006/835327 17149456
    [Google Scholar]
  36. van Kooten J. Binnekade T.T. van der Wouden J.C. Stek M.L. Scherder E.J.A. Husebø B.S. Smalbrugge M. Hertogh C.M.P.M. A review of pain prevalence in Alzheimer’s, vascular, frontotemporal and Lewy body dementias. Dement. Geriatr. Cogn. Disord. 2016 41 3-4 220 232 10.1159/000444791 27160163
    [Google Scholar]
  37. Rajkumar A.P. Ballard C. Fossey J. Orrell M. Moniz-Cook E. Woods R.T. Murray J. Whitaker R. Stafford J. Knapp M. Romeo R. Woodward-Carlton B. Khan Z. Testad I. Corbett A. Epidemiology of pain in people with dementia living in care homes longitudinal course, prevalence, and treatment implications. J. Am. Med. Dir. Assoc. 2017 18 5 453.e1 453.e6 10.1016/j.jamda.2017.01.024 28330634
    [Google Scholar]
  38. Hayashida K. Obata H. Strategies to treat chronic pain and strengthen impaired descending noradrenergic inhibitory system. Int. J. Mol. Sci. 2019 20 4 822 10.3390/ijms20040822 30769838
    [Google Scholar]
  39. Tozaki-Saitoh H. Sasaki I. Yamashita T. Hosoi M. Kato T.A. Tsuda M. Involvement of exchange protein directly activated by cAMP and tumor progression locus 2 in IL-1β production in microglial cells following activation of β-adrenergic receptors. J. Pharmacol. Sci. 2020 143 3 133 140 10.1016/j.jphs.2020.03.004 32253104
    [Google Scholar]
  40. Ezzati A. Wang C. Katz M.J. Derby C.A. Zammit A.R. Zimmerman M.E. Pavlovic J.M. Sliwinski M.J. Lipton R.B. The temporal relationship between pain intensity and pain interference and incident dementia. Curr. Alzheimer Res. 2019 16 2 109 115 10.2174/1567205016666181212162424 30543173
    [Google Scholar]
  41. Malfliet A. Coppieters I. Van Wilgen P. Kregel J. De Pauw R. Dolphens M. Ickmans K. Brain changes associated with cognitive and emotional factors in chronic pain: A systematic review. Eur. J. Pain 2017 21 5 769 786 10.1002/ejp.1003 28146315
    [Google Scholar]
  42. Ma T. Ji Y.Y. Yan L.F. Lin J.J. Li Z.Y. Wang W. Li J.L. Cui G.B. Gray matter volume abnormality in chronic pain patients with depressive symptoms: A systemic review and meta-analysis of voxel-based morphometry studies. Front. Neurosci. 2022 16 826759 10.3389/fnins.2022.826759 35733934
    [Google Scholar]
  43. Zhang Y. Yu T. Qin B. Li Y. Song G. Yu B. Microstructural abnormalities in gray matter of patients with postherpetic neuralgia: A diffusional kurtosis imaging study. Pain Physician 2016 19 4 E601 E611 27228526
    [Google Scholar]
  44. Mutso A.A. Radzicki D. Baliki M.N. Huang L. Banisadr G. Centeno M.V. Radulovic J. Martina M. Miller R.J. Apkarian A.V. Abnormalities in hippocampal functioning with persistent pain. J. Neurosci. 2012 32 17 5747 5756 10.1523/JNEUROSCI.0587‑12.2012 22539837
    [Google Scholar]
  45. Seminowicz D.A. Wideman T.H. Naso L. Hatami-Khoroushahi Z. Fallatah S. Ware M.A. Jarzem P. Bushnell M.C. Shir Y. Ouellet J.A. Stone L.S. Effective treatment of chronic low back pain in humans reverses abnormal brain anatomy and function. J. Neurosci. 2011 31 20 7540 7550 10.1523/JNEUROSCI.5280‑10.2011 21593339
    [Google Scholar]
  46. Pless A. Ware D. Saggu S. Rehman H. Morgan J. Wang Q. Understanding neuropsychiatric symptoms in Alzheimer’s disease: Challenges and advances in diagnosis and treatment. Front. Neurosci. 2023 17 1263771 10.3389/fnins.2023.1263771 37732300
    [Google Scholar]
  47. van der Steen J.T. Radbruch L. Hertogh C.M.P.M. de Boer M.E. Hughes J.C. Larkin P. Francke A.L. Jünger S. Gove D. Firth P. Koopmans R.T.C.M. Volicer L. White paper defining optimal palliative care in older people with dementia: A delphi study and recommendations from the european association for palliative care. Palliat. Med. 2014 28 3 197 209 10.1177/0269216313493685 23828874
    [Google Scholar]
  48. Cummings J.L. Mega M. Gray K. Rosenberg-Thompson S. Carusi D.A. Gornbein J. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994 44 12 2308 2314 10.1212/WNL.44.12.2308 7991117
    [Google Scholar]
  49. Chaudhary S. Zhornitsky S. Chao H.H. van Dyck C.H. Li C.S.R. Emotion processing dysfunction in Alzheimer’s disease: An overview of behavioral findings, systems neural correlates, and underlying neural biology. Am. J. Alzheimers Dis. Other Demen. 2022 37 15333175221082834 10.1177/15333175221082834 35357236
    [Google Scholar]
  50. Whitlock E.L. Diaz-Ramirez L.G. Glymour M.M. Boscardin W.J. Covinsky K.E. Smith A.K. Association between persistent pain and memory decline and dementia in a longitudinal cohort of elders. JAMA Intern. Med. 2017 177 8 1146 1153 10.1001/jamainternmed.2017.1622 28586818
    [Google Scholar]
  51. Kolanowski A. Mogle J. Fick D.M. Hill N. Mulhall P. Nadler J. Colancecco E. Behrens L. Pain, delirium, and physical function in skilled nursing home patients with dementia. J. Am. Med. Dir. Assoc. 2015 16 1 37 40 10.1016/j.jamda.2014.07.002 25239018
    [Google Scholar]
  52. Innes K.E. Sambamoorthi U. The potential contribution of chronic pain and common chronic pain conditions to subsequent cognitive decline, new onset cognitive impairment, and incident dementia: A systematic review and conceptual model for future research. J. Alzheimers Dis. 2020 78 3 1177 1195 10.3233/JAD‑200960 33252087
    [Google Scholar]
  53. Yuan H. Ahmed W.L. Liu M. Tu S. Zhou F. Wang S. Contribution of pain to subsequent cognitive decline or dementia: A systematic review and meta-analysis of cohort studies. Int. J. Nurs. Stud. 2023 138 104409 10.1016/j.ijnurstu.2022.104409 36527860
    [Google Scholar]
  54. Tian J. Jones G. Lin X. Zhou Y. King A. Vickers J. Pan F. Association between chronic pain and risk of incident dementia: Findings from a prospective cohort. BMC Med. 2023 21 1 169 10.1186/s12916‑023‑02875‑x 37143042
    [Google Scholar]
  55. Zhao W. Zhao L. Chang X. Lu X. Tu Y. Elevated dementia risk, cognitive decline, and hippocampal atrophy in multisite chronic pain. Proc. Natl. Acad. Sci. USA 2023 120 9 e2215192120 10.1073/pnas.2215192120 36802440
    [Google Scholar]
  56. Bornier N. Mulliez A. Chenaf C. Elyn A. Teixeira S. Authier N. Bertin C. Kerckhove N. Chronic pain is a risk factor for incident Alzheimer’s disease: A nationwide propensity-matched cohort using administrative data. Front. Aging Neurosci. 2023 15 1193108 10.3389/fnagi.2023.1193108 37842123
    [Google Scholar]
  57. Xia S.H. Hu S.W. Ge D.G. Liu D. Wang D. Zhang S. Zhang Q. Yuan L. Li Y.Q. Yang J.X. Wu P. Zhang H. Han M.H. Ding H.L. Cao J.L. Chronic pain impairs memory formation via Disruption of neurogenesis mediated by mesohippocampal brain-derived neurotrophic factor signaling. Biol. Psychiatry 2020 88 8 597 610 10.1016/j.biopsych.2020.02.013 32307038
    [Google Scholar]
  58. Chen L. Qin Q. Huang P. Cao F. Yin M. Xie Y. Wang W. Chronic pain accelerates cognitive impairment by reducing hippocampal neurogenesis may via CCL2/CCR2 signaling in APP/PS1 mice. Brain Res. Bull. 2023 205 110801 10.1016/j.brainresbull.2023.110801 37931808
    [Google Scholar]
  59. Palesi F. Castellazzi G. Casiraghi L. Sinforiani E. Vitali P. Gandini Wheeler-Kingshott C.A.M. D’Angelo E. Exploring patterns of alteration in Alzheimer’s disease brain networks: A combined structural and functional connectomics analysis. Front. Neurosci. 2016 10 380 10.3389/fnins.2016.00380 27656119
    [Google Scholar]
  60. Lawn T. Aman Y. Rukavina K. Sideris-Lampretsas G. Howard M. Ballard C. Ray Chaudhuri K. Malcangio M. Pain in the neurodegenerating brain: Insights into pharmacotherapy for Alzheimer disease and Parkinson disease. Pain 2021 162 4 999 1006 10.1097/j.pain.0000000000002111 33239526
    [Google Scholar]
  61. Cole L.J. Farrell M.J. Duff E.P. Barber J.B. Egan G.F. Gibson S.J. Pain sensitivity and fMRI pain-related brain activity in Alzheimer’s disease. Brain 2006 129 11 2957 2965 10.1093/brain/awl228 16951408
    [Google Scholar]
  62. Stubbs B. Thompson T. Solmi M. Vancampfort D. Sergi G. Luchini C. Veronese N. Is pain sensitivity altered in people with Alzheimer’s disease? A systematic review and meta-analysis of experimental pain research. Exp. Gerontol. 2016 82 30 38 10.1016/j.exger.2016.05.016 27262688
    [Google Scholar]
  63. Llorca-Torralba M. Borges G. Neto F. Mico J.A. Berrocoso E. Noradrenergic locus coeruleus pathways in pain modulation. Neuroscience 2016 338 93 113 10.1016/j.neuroscience.2016.05.057 27267247
    [Google Scholar]
  64. Gannon M. Che P. Chen Y. Jiao K. Roberson E.D. Wang Q. Noradrenergic dysfunction in Alzheimer’s disease. Front. Neurosci. 2015 9 220 10.3389/fnins.2015.00220 26136654
    [Google Scholar]
  65. Chen Y. Chen T. Hou R. Locus coeruleus in the pathogenesis of Alzheimer’s disease: A systematic review. Alzheimers Dement. (N. Y.) 2022 8 1 e12257 10.1002/trc2.12257 35282658
    [Google Scholar]
  66. German D.C. Manaye K.F. White C.L. III Woodward D.J. McIntire D.D. Smith W.K. Kalaria R.N. Mann D.M.A. Disease-specific patterns of locus coeruleus cell loss. Ann. Neurol. 1992 32 5 667 676 10.1002/ana.410320510 1449247
    [Google Scholar]
  67. Andrade-Moraes C.H. Oliveira-Pinto A.V. Castro-Fonseca E. da Silva C.G. Guimarães D.M. Szczupak D. Parente-Bruno D.R. Carvalho L.R.B. Polichiso L. Gomes B.V. Oliveira L.M. Rodriguez R.D. Leite R.E.P. Ferretti-Rebustini R.E.L. Jacob-Filho W. Pasqualucci C.A. Grinberg L.T. Lent R. Cell number changes in Alzheimer’s disease relate to dementia, not to plaques and tangles. Brain 2013 136 12 3738 3752 10.1093/brain/awt273 24136825
    [Google Scholar]
  68. Gulyás B. Brockschnieder D. Nag S. Pavlova E. Kása P. Beliczai Z. Légrádi Á. Gulya K. Thiele A. Dyrks T. Halldin C. The norepinephrine transporter (NET) radioligand (S,S)-[18F]FMeNER-D2 shows significant decreases in NET density in the human brain in alzheimer’s disease: A post-mortem autoradiographic study. Neurochem. Int. 2010 56 6-7 789 798 10.1016/j.neuint.2010.03.001 20211213
    [Google Scholar]
  69. Matthews K.L. Chen C.P.L.H. Esiri M.M. Keene J. Minger S.L. Francis P.T. Noradrenergic changes, aggressive behavior, and cognition in patients with dementia. Biol. Psychiatry 2002 51 5 407 416 10.1016/S0006‑3223(01)01235‑5 11904135
    [Google Scholar]
  70. Elrod R. Peskind E.R. DiGiacomo L. Brodkin K.I. Veith R.C. Raskind M.A. Effects of alzheimer’s disease severity on cerebrospinal fluid norepinephrine concentration. Am. J. Psychiatry 1997 154 1 25 30 10.1176/ajp.154.1.25 8988954
    [Google Scholar]
  71. Mravec B. Lejavova K. Vargovic P. Ondicova K. Horvathova L. Novak P. Manz G. Filipcik P. Novak M. Kvetnansky R. Tauopathy in transgenic (SHR72) rats impairs function of central noradrenergic system and promotes neuroinflammation. J. Neuroinflammation 2016 13 1 15 10.1186/s12974‑016‑0482‑1 26792515
    [Google Scholar]
  72. Itoi K. Ohara S. Kobayashi K. Selective ablation of dopamine β-hydroxylase neurons in the brain by immunotoxin-mediated neuronal targeting: New insights into brain catecholaminergic circuitry and catecholamine-related diseases. Adv. Pharmacol. 2013 68 155 166 10.1016/B978‑0‑12‑411512‑5.00008‑7 24054144
    [Google Scholar]
  73. Barnard D.F. Gabella K.M. Kulp A.C. Parker A.D. Dugan P.B. Johnson J.D. Sex differences in the regulation of brain IL-1β in response to chronic stress. Psychoneuroendocrinology 2019 103 203 211 10.1016/j.psyneuen.2019.01.026 30711897
    [Google Scholar]
  74. Mori K. Ozaki E. Zhang B. Yang L. Yokoyama A. Takeda I. Maeda N. Sakanaka M. Tanaka J. Effects of norepinephrine on rat cultured microglial cells that express α1, α2, β1 and β2 adrenergic receptors. Neuropharmacology 2002 43 6 1026 1034 10.1016/S0028‑3908(02)00211‑3 12423672
    [Google Scholar]
  75. Schlachetzki J.C.M. Fiebich B.L. Haake E. de Oliveira A.C.P. Candelario-Jalil E. Heneka M.T. Hüll M. Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia. J. Neuroinflammation 2010 7 1 2 10.1186/1742‑2094‑7‑2 20064241
    [Google Scholar]
  76. Kato T.A. Yamauchi Y. Horikawa H. Monji A. Mizoguchi Y. Seki Y. Hayakawa K. Utsumi H. Kanba S. Neurotransmitters, psychotropic drugs and microglia: Clinical implications for psychiatry. Curr. Med. Chem. 2013 20 3 331 344 23157624
    [Google Scholar]
  77. Théry C. Dobbertin A. Mallat M. Downregulation of in vitro neurotoxicity of brain macrophages by prostaglandin E2 and a β-adrenergic agonist. Glia 1994 11 4 383 386 10.1002/glia.440110411 7960041
    [Google Scholar]
  78. Färber K. Pannasch U. Kettenmann H. Dopamine and noradrenaline control distinct functions in rodent microglial cells. Mol. Cell. Neurosci. 2005 29 1 128 138 10.1016/j.mcn.2005.01.003 15866053
    [Google Scholar]
  79. Heneka M.T. Carson M.J. Khoury J.E. Landreth G.E. Brosseron F. Feinstein D.L. Jacobs A.H. Wyss-Coray T. Vitorica J. Ransohoff R.M. Herrup K. Frautschy S.A. Finsen B. Brown G.C. Verkhratsky A. Yamanaka K. Koistinaho J. Latz E. Halle A. Petzold G.C. Town T. Morgan D. Shinohara M.L. Perry V.H. Holmes C. Bazan N.G. Brooks D.J. Hunot S. Joseph B. Deigendesch N. Garaschuk O. Boddeke E. Dinarello C.A. Breitner J.C. Cole G.M. Golenbock D.T. Kummer M.P. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015 14 4 388 405 10.1016/S1474‑4422(15)70016‑5 25792098
    [Google Scholar]
  80. Rainero I. Vighetti S. Bergamasco B. Pinessi L. Benedetti F. Autonomic responses and pain perception in Alzheimer’s disease. Eur. J. Pain 2000 4 3 267 274 10.1053/eujp.2000.0185 10985870
    [Google Scholar]
  81. Pieper M.J.C. van Dalen-Kok A.H. Francke A.L. van der Steen J.T. Scherder E.J.A. Husebø B.S. Achterberg W.P. Interventions targeting pain or behaviour in dementia: A systematic review. Ageing Res. Rev. 2013 12 4 1042 1055 10.1016/j.arr.2013.05.002 23727161
    [Google Scholar]
  82. Shropshire M. Stapleton S.J. Dyck M.J. Kim M. Mallory C. Nonpharmacological interventions for persistent, noncancer pain in elders residing in long-term care facilities: An integrative review of the literature. Nurs. Forum 2018 53 4 538 548 10.1111/nuf.12284 30242833
    [Google Scholar]
  83. Anderson A.R. Deng J. Anthony R.S. Atalla S.A. Monroe T.B. Using complementary and alternative medicine to treat pain and agitation in dementia: A review of randomized controlled trials from long-term care with potential use in critical care. Crit. Care Nurs. Clin. North Am. 2017 29 4 519 537 10.1016/j.cnc.2017.08.010 29107312
    [Google Scholar]
  84. La Frenais F.L. Bedder R. Vickerstaff V. Stone P. Sampson E.L. Temporal trends in analgesic use in long-term care facilities: A systematic review of international prescribing. J. Am. Geriatr. Soc. 2018 66 2 376 382 10.1111/jgs.15238 29274247
    [Google Scholar]
  85. Erdal A. Ballard C. Vahia I.V. Husebo B.S. Analgesic treatments in people with dementia - how safe are they? A systematic review. Expert Opin. Drug Saf. 2019 18 6 511 522 10.1080/14740338.2019.1614166 31038371
    [Google Scholar]
  86. Sandvik R. Selbaek G. Kirkevold O. Husebo B.S. Aarsland D. Analgesic prescribing patterns in Norwegian nursing homes from 2000 to 2011: Trend analyses of four data samples. Age Ageing 2016 45 1 54 60 10.1093/ageing/afv184 26764395
    [Google Scholar]
  87. Tan E.C.K. Visvanathan R. Hilmer S.N. Vitry A. Emery T. Robson L. Pitkälä K. Ilomäki J. Bell J.S. Analgesic use and pain in residents with and without dementia in aged care facilities: A cross-sectional study. Australas. J. Ageing 2016 35 3 180 187 10.1111/ajag.12295 27256958
    [Google Scholar]
  88. Sandvik R.K. Selbaek G. Seifert R. Aarsland D. Ballard C. Corbett A. Husebo B.S. Impact of a stepwise protocol for treating pain on pain intensity in nursing home patients with dementia: A cluster randomized trial. Eur. J. Pain 2014 18 10 1490 1500 10.1002/ejp.523 24819710
    [Google Scholar]
  89. Gustavsson A. Norton N. Fast T. Frölich L. Georges J. Holzapfel D. Kirabali T. Krolak-Salmon P. Rossini P.M. Ferretti M.T. Lanman L. Chadha A.S. van der Flier W.M. Global estimates on the number of persons across the alzheimer’s disease continuum. Alzheimers Dement. 2023 19 2 658 670 10.1002/alz.12694 35652476
    [Google Scholar]
  90. Blanton H. Reddy P.H. Benamar K. Chronic pain in alzheimer’s disease: Endocannabinoid system. Exp. Neurol. 2023 360 114287 10.1016/j.expneurol.2022.114287 36455638
    [Google Scholar]
  91. Finn D.P. Haroutounian S. Hohmann A.G. Krane E. Soliman N. Rice A.S.C. Cannabinoids, the endocannabinoid system, and pain: A review of preclinical studies. Pain 2021 162 1 S5 S25 10.1097/j.pain.0000000000002268 33729211
    [Google Scholar]
  92. Abate G. Uberti D. Tambaro S. Potential and limits of cannabinoids in Alzheimer’s disease therapy. Biology (Basel) 2021 10 6 542 10.3390/biology10060542 34204237
    [Google Scholar]
  93. Abdulla A. Adams N. Bone M. Elliott A.M. Gaffin J. Jones D. Knaggs R. Martin D. Sampson L. Schofield P. Guidance on the management of pain in older people. Age Ageing 2013 42 Suppl. 1 i1 i57 10.1093/ageing/afs199 23420266
    [Google Scholar]
  94. Tick H. Nielsen A. Pelletier K.R. Bonakdar R. Simmons S. Glick R. Ratner E. Lemmon R.L. Wayne P. Zador V. Evidence-based nonpharmacologic strategies for comprehensive pain care: The consortium pain task force white paper. Explore (NY) 2018 14 3 177 211 10.1016/j.explore.2018.02.001 29735382
    [Google Scholar]
  95. Achterberg W. Lautenbacher S. Husebo B. Erdal A. Herr K. Pain in dementia. Pain Rep. 2020 5 1 e803 10.1097/PR9.0000000000000803 32072098
    [Google Scholar]
/content/journals/cmc/10.2174/0109298673334477250204072429
Loading
Mechanisms and Characteristics of Chronic Pain in Alzheimer’s Disease: A Narrative Review
Bentham Science Publishers ; https://doi.org/10.2174/0109298673334477250204072429
/content/journals/cmc/10.2174/0109298673334477250204072429
/content/journals/cmc/10.2174/0109298673334477250204072429
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: dementia ; opioids ; non-pharmacological interventions ; pain ; chronic pain management ; NSAIDs ; Alzheimer’s disease ; paracetamol

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test